1. Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells. (February 2017) Authors: Sesumi, Yuichi; Suda, Kenichi; Mizuuchi, Hiroshi; Kobayashi, Yoshihisa; Sato, Katsuaki; Chiba, Masato; Shimoji, Masaki; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 104(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer. (January 2016) Authors: Suda, Kenichi; Murakami, Isao; Sakai, Kazuko; Tomizawa, Kenji; Mizuuchi, Hiroshi; Sato, Katsuaki; Nishio, Kazuto; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 91(2016) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer. (January 2016) Authors: Suda, Kenichi; Murakami, Isao; Sakai, Kazuko; Tomizawa, Kenji; Mizuuchi, Hiroshi; Sato, Katsuaki; Nishio, Kazuto; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 91(2016) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of bevacizumab in combination with erlotinib on EGFR‐mutated non–small cell lung cancer xenograft models with T790M mutation or MET amplification. Issue 4 (13th October 2015) Authors: Furugaki, Koh; Fukumura, Junko; Iwai, Toshiki; Yorozu, Keigo; Kurasawa, Mitsue; Yanagisawa, Mieko; Moriya, Yoichiro; Yamamoto, Kaname; Suda, Kenichi; Mizuuchi, Hiroshi; Mitsudomi, Tetsuya; Harada, Naoki Journal: International journal of cancer Issue: Volume 138:Issue 4(2016:Feb. 15) Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor. Issue 3 (December 2015) Authors: Togashi, Yosuke; Mizuuchi, Hiroshi; Tomida, Shuta; Terashima, Masato; Hayashi, Hidetoshi; Nishio, Kazuto; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 90:Issue 3(2015:Dec.) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor in lung cancer. Issue 4 (28th March 2016) Authors: Mizuuchi, Hiroshi; Suda, Kenichi; Murakami, Isao; Sakai, Kazuko; Sato, Katsuaki; Kobayashi, Yoshihisa; Shimoji, Masaki; Chiba, Masato; Sesumi, Yuichi; Tomizawa, Kenji; Takemoto, Toshiki; Sekido, Yoshitaka; Nishio, Kazuto; Mitsudomi, Tetsuya Journal: Cancer science Issue: Volume 107:Issue 4(2016) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Solitary pulmonary metastasis from malignant melanoma of the bulbar conjunctiva presenting as a pulmonary ground glass nodule: Report of a case. Issue 1 (January 2015) Authors: Mizuuchi, Hiroshi; Suda, Kenichi; Kitahara, Hirokazu; Shimamatsu, Shinichiro; Kohno, Mikihiro; Okamoto, Tatsuro; Maehara, Yoshihiko Journal: Thoracic cancer Issue: Volume 6:Issue 1(2015) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The insulin‐like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild‐type epidermal growth factor receptor. Issue 4 (4th February 2014) Authors: Suda, Kenichi; Mizuuchi, Hiroshi; Sato, Katsuaki; Takemoto, Toshiki; Iwasaki, Takuya; Mitsudomi, Tetsuya Journal: International journal of cancer Issue: Volume 135:Issue 4(2014:Aug. 15) Page Start: 1002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗